首页> 中文期刊> 《中国结合医学杂志:英文版》 >Clinical Studies on Treatment of Acute Cerebral Infarction with Xueshuantong(血栓通)Injection

Clinical Studies on Treatment of Acute Cerebral Infarction with Xueshuantong(血栓通)Injection

         

摘要

Objective:To observe the effect of Xueshuantong injection(XST,血栓通注射液)with its ingredient as Notoginseng saponin,on acute cerebral infarction(ACI) and on blood coagulation and fibri-nolysis,so as to comprehensively analyse the mechanism of XST.Methods:Fifty ACI patients were ran-domly divided into 2 groups,and XST group(30 patients)was treated with XST, and the control group (20 patients)given low molecular dextrose,as well as low molecular heparin calcium.The course of treat-ment for both groups was 15 days.The changes of effective rate,score of neurologic impairment,tissue-type plasminogen activator(tPA),inhibitor of plasminogen activator(PAI),D-D dimmer,antithrombin-Ⅲ(AT-Ⅲ),and fibrinogen(Fbg) were all observed.Results:The total effective rate of XST group was 73.33%,that of the control group 65.00%.After the therapy,plasma level of tPA,ratio of tPA/PAI,and AT-Ⅲ content were increased obviously,while the plasma level of PAI and D-D dimmer were de-creased significantly(all P0.05).Conclusion:XST injection could be effective to ACI, the mechanism of which is probably related to improving the balance between plasminogen activator and its inhibitory factor,increasing the acitvity of fi-brinolysin,inactivating thrombin,inhibiting platelet aggregation induced by thrombin,and decreasing blood coagulation.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号